Last reviewed · How we verify
Placebo of Hepalatide
Placebo of Hepalatide is a Small molecule drug developed by Shanghai HEP Pharmaceutical Co., Ltd.. It is currently in Phase 3 development. Also known as: Placebo.
This is a placebo control formulation used in clinical trials and does not exert any active pharmacological effect.
At a glance
| Generic name | Placebo of Hepalatide |
|---|---|
| Also known as | Placebo |
| Sponsor | Shanghai HEP Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, this formulation contains no active pharmaceutical ingredient and serves as a control comparator in clinical studies to assess the efficacy and safety of Hepalatide itself. Placebos are essential for blinded trial designs to distinguish true drug effects from placebo response and natural disease progression.
Approved indications
Common side effects
Key clinical trials
- Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D (PHASE3)
- A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B (PHASE2)
- A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients (PHASE2)
- Study of Hepalatide in Chronic Hepatitis D(CHD) Patients (PHASE2)
- A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin (PHASE1, PHASE2)
- Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers (PHASE1)
- Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Hepalatide CI brief — competitive landscape report
- Placebo of Hepalatide updates RSS · CI watch RSS
- Shanghai HEP Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Placebo of Hepalatide
What is Placebo of Hepalatide?
How does Placebo of Hepalatide work?
Who makes Placebo of Hepalatide?
Is Placebo of Hepalatide also known as anything else?
What development phase is Placebo of Hepalatide in?
Related
- Manufacturer: Shanghai HEP Pharmaceutical Co., Ltd. — full pipeline
- Also known as: Placebo
- Compare: Placebo of Hepalatide vs similar drugs
- Pricing: Placebo of Hepalatide cost, discount & access